Mr Dennis Tan Lip Fong asked the Minister for Health whether the Ministry can consider extending the Vaccine Injury Financial Assistance Programme for COVID-19 Vaccination or other forms of financial assistance to Singaporeans who have suffered from psoriasis as a related side effect of COVID-19 vaccination, notwithstanding that it might not have resulted in any inpatient hospitalisation or any permanent severe disability.
Mr Ong Ye Kung: Eligibility for the Vaccine Injury Financial Assistance Programme (VIFAP) is determined by an independent clinical panel, who will consider: (a) whether the side effect is likely to be caused by vaccination or other factors, such as underlying health conditions; and (b) the severity of the side effect caused by the vaccination.
A serious side effect is typically considered one that minimally required hospitalisation. Cases that were not hospitalised but require long-term follow-up, including that of skin conditions, are also reviewed for assistance on a case-by-case basis.
Ministry of Health
7 November 2022
https://sprs.parl.gov.sg/search/#/sprs3topic?reportid=written-answer-na-11848
Office of the Leader of the Opposition 